359 related articles for article (PubMed ID: 34073529)
1. Could Histamine H1 Receptor Antagonists Be Used for Treating COVID-19?
Qu C; Fuhler GM; Pan Y
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073529
[TBL] [Abstract][Full Text] [Related]
2. Repositioning of histamine H
Ge S; Wang X; Hou Y; Lv Y; Wang C; He H
Eur J Pharmacol; 2021 Apr; 896():173897. PubMed ID: 33497607
[TBL] [Abstract][Full Text] [Related]
3. Histamine H1-receptor antagonists inhibit nuclear factor-kappaB and activator protein-1 activities via H1-receptor-dependent and -independent mechanisms.
Roumestan C; Henriquet C; Gougat C; Michel A; Bichon F; Portet K; Jaffuel D; Mathieu M
Clin Exp Allergy; 2008 Jun; 38(6):947-56. PubMed ID: 18498541
[TBL] [Abstract][Full Text] [Related]
4. Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathway.
Ma Q; Li R; Pan W; Huang W; Liu B; Xie Y; Wang Z; Li C; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Hui M; Fu L; Yang Z
Phytomedicine; 2020 Nov; 78():153296. PubMed ID: 32890913
[TBL] [Abstract][Full Text] [Related]
5. Histamine receptors and COVID-19.
Ennis M; Tiligada K
Inflamm Res; 2021 Jan; 70(1):67-75. PubMed ID: 33206207
[TBL] [Abstract][Full Text] [Related]
6. Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.
Ma Q; Pan W; Li R; Liu B; Li C; Xie Y; Wang Z; Zhao J; Jiang H; Huang J; Shi Y; Dai J; Zheng K; Li X; Yang Z
Pharmacol Res; 2020 Aug; 158():104850. PubMed ID: 32360580
[TBL] [Abstract][Full Text] [Related]
7. Histamine H1 receptor antagonist blocks histamine-induced proinflammatory cytokine production through inhibition of Ca2+-dependent protein kinase C, Raf/MEK/ERK and IKK/I kappa B/NF-kappa B signal cascades.
Matsubara M; Tamura T; Ohmori K; Hasegawa K
Biochem Pharmacol; 2005 Feb; 69(3):433-49. PubMed ID: 15652235
[TBL] [Abstract][Full Text] [Related]
8. Letter to the Editor in response to the articles 'Lianhuaqingwen exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2)' and 'Liu Shen capsule shows antiviral and anti-inflammatory abilities against novel coronavirus SARS-CoV-2 via suppression of NF-κB signaling pathway.'.
Huang X; Zhao Q; Xia L; Shi S
Pharmacol Res; 2021 Jan; 163():105289. PubMed ID: 33197600
[No Abstract] [Full Text] [Related]
9. Desloratadine inhibits constitutive and histamine-stimulated nuclear factor-kappaB activity consistent with inverse agonism at the histamine H1 Receptor.
Wu RL; Anthes JC; Kreutner W; Harris AG; West RE
Int Arch Allergy Immunol; 2004 Dec; 135(4):313-8. PubMed ID: 15564772
[TBL] [Abstract][Full Text] [Related]
10. Antihistamine and cationic amphiphilic drugs, old molecules as new tools against the COVID-19?
Gitahy Falcao Faria C; Weiner L; Petrignet J; Hingray C; Ruiz De Pellon Santamaria Á; Villoutreix BO; Beaune P; Leboyer M; Javelot H
Med Hypotheses; 2021 Mar; 148():110508. PubMed ID: 33571758
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine A Inhibits Viral Infection and Release as Well as Cytokine Production in Lung Cells by Three SARS-CoV-2 Variants.
Fenizia C; Galbiati S; Vanetti C; Vago R; Clerici M; Tacchetti C; Daniele T
Microbiol Spectr; 2022 Feb; 10(1):e0150421. PubMed ID: 34985303
[TBL] [Abstract][Full Text] [Related]
12. Identification of antiviral antihistamines for COVID-19 repurposing.
Reznikov LR; Norris MH; Vashisht R; Bluhm AP; Li D; Liao YJ; Brown A; Butte AJ; Ostrov DA
Biochem Biophys Res Commun; 2021 Jan; 538():173-179. PubMed ID: 33309272
[TBL] [Abstract][Full Text] [Related]
13. Histamine H(1)-receptor activation of nuclear factor-kappa B: roles for G beta gamma- and G alpha(q/11)-subunits in constitutive and agonist-mediated signaling.
Bakker RA; Schoonus SB; Smit MJ; Timmerman H; Leurs R
Mol Pharmacol; 2001 Nov; 60(5):1133-42. PubMed ID: 11641442
[TBL] [Abstract][Full Text] [Related]
14. Endoplasmic reticulum stress and NF-kB activation in SARS-CoV-2 infected cells and their response to antiviral therapy.
Bartolini D; Stabile AM; Vacca C; Pistilli A; Rende M; Gioiello A; Cruciani G; Galli F
IUBMB Life; 2022 Jan; 74(1):93-100. PubMed ID: 34390301
[TBL] [Abstract][Full Text] [Related]
15. Regulation of histamine H1 receptor coupling by dexamethasone in human cultured airway smooth muscle.
Hardy E; Farahani M; Hall IP
Br J Pharmacol; 1996 Jun; 118(4):1079-84. PubMed ID: 8799585
[TBL] [Abstract][Full Text] [Related]
16. Niclosamide for Covid-19: bridging the gap.
Al-Kuraishy HM; Al-Gareeb AI; Alzahrani KJ; Alexiou A; Batiha GE
Mol Biol Rep; 2021 Dec; 48(12):8195-8202. PubMed ID: 34664162
[TBL] [Abstract][Full Text] [Related]
17. Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action.
Yousefi H; Mashouri L; Okpechi SC; Alahari N; Alahari SK
Biochem Pharmacol; 2021 Jan; 183():114296. PubMed ID: 33191206
[TBL] [Abstract][Full Text] [Related]
18. H1-antihistamines: inverse agonism, anti-inflammatory actions and cardiac effects.
Leurs R; Church MK; Taglialatela M
Clin Exp Allergy; 2002 Apr; 32(4):489-98. PubMed ID: 11972592
[TBL] [Abstract][Full Text] [Related]
19. Systems pharmacological study illustrates the immune regulation, anti-infection, anti-inflammation, and multi-organ protection mechanism of Qing-Fei-Pai-Du decoction in the treatment of COVID-19.
Zhao J; Tian S; Lu D; Yang J; Zeng H; Zhang F; Tu D; Ge G; Zheng Y; Shi T; Xu X; Zhao S; Yang Y; Zhang W
Phytomedicine; 2021 May; 85():153315. PubMed ID: 32978039
[TBL] [Abstract][Full Text] [Related]
20. Famotidine inhibits toll-like receptor 3-mediated inflammatory signaling in SARS-CoV-2 infection.
Mukherjee R; Bhattacharya A; Bojkova D; Mehdipour AR; Shin D; Khan KS; Hei-Yin Cheung H; Wong KB; Ng WL; Cinatl J; Geurink PP; van der Heden van Noort GJ; Rajalingam K; Ciesek S; Hummer G; Dikic I
J Biol Chem; 2021 Aug; 297(2):100925. PubMed ID: 34214498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
